The 20 Best Necrosis Doctors Near Me in Charleston,, SC

Jeffrey Rieder is a Cardiologist in Charleston, South Carolina. Dr. Rieder is rated as a Distinguished provider by MediFind in the treatment of Necrosis. His top areas of expertise are Arrhythmias, Sick Sinus Syndrome, Atherosclerosis, Pacemaker Implantation, and Cardiac Ablation.

Troy Bunting is a Cardiologist in Charleston,, South Carolina. Dr. Bunting is rated as a Distinguished provider by MediFind in the treatment of Necrosis. His top areas of expertise are Coronary Heart Disease, Necrosis, Atherosclerosis, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Matthew O'steen is a Cardiologist in Charleston,, South Carolina. Dr. O'steen is rated as a Distinguished provider by MediFind in the treatment of Necrosis. His top areas of expertise are Atrial Fibrillation, Coronary Heart Disease, Atherosclerosis, Pacemaker Implantation, and Heart Valve Repair.

Scott Woodfield is a Cardiologist in Charleston,, South Carolina. Dr. Woodfield is rated as a Distinguished provider by MediFind in the treatment of Necrosis. His top areas of expertise are Coronary Heart Disease, Pediatric Myocarditis, Hypertensive Heart Disease, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Lars Runquist is a Cardiologist in Charleston,, South Carolina. Dr. Runquist is rated as a Distinguished provider by MediFind in the treatment of Necrosis. His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Arrhythmias, Pacemaker Implantation, and Cardiac Ablation.

Daniel Steinberg, MD, specializes in Interventional Cardiology. Dr. Steinberg is rated as a Distinguished provider by MediFind in the treatment of Necrosis. His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Supravalvular Aortic Stenosis, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Dr. Nawabi brings over 24 years of cardiology experience to MUSC, including 15 years as an invasive cardiologist in private practice in the Upstate. Over the past nine years, she has focused on general noninvasive cardiology in a community setting, prioritizing patient-centered care. Her special interests include coronary CT angiography, womens cardiac health, cardio-oncology, and preventive cardiology. Dr. Nawabi is honored and excited to serve the Lowcountry community. Dr. Nawabi is rated as an Advanced provider by MediFind in the treatment of Necrosis. Her top areas of expertise are Atrial Fibrillation, Pediatric Myocarditis, Necrosis, and Mitral Valve Regurgitation.

"Brittany Bankhead, M.D., recently joined the Department of Surgery as an associate professor. Dr. Bankhead is a double-board certified trauma and general surgeon and a surgical intensivist. Before joining MUSC, she was an assistant professor of surgery at Texas Tech University Health Sciences Center (TTUHSC). This fall, she was awarded the President's Innovation Award at TTUHSC and the prestigious ""40 under 40"" award by the Association of Women Surgeons.During her time as the Stop the Bleed State Champion of Texas for the Committee on Trauma, she saw a need for improved hemorrhage control training. She built a multidisciplinary regional team that was accepted into the National Science Foundation's Innovation Corps (NSF I-Corps), an immersive, entrepreneurial training program. During this prestigious program, Dr. Bankhead's team shifted their focus for commercialization from solely local injury prevention to also include improved military biofeedback hemorrhage control training. Dr. Bankhead's team received regional and national funding, including a $50,000 grant for the NSF iCorps award.She most recently was selected, among a large national cohort, to present her medical technology in Washington, DC, at a multidisciplinary innovation conference with large military and federal influence. This has given her the ability to continue to work towards her future goals of large-scale NIH federal innovation funding and commercialization with a military focus. Dr. Bankhead is looking forward to multidisciplinary collaboration and helping grow the network of research and commercialization opportunities at MUSC.During the peak of the COVID-19 pandemic, Dr. Bankhead was part of the inaugural international group ""CovidSurg"" through the National Institute for Health Research Unit on Global Surgery in the United Kingdom. Her experiences and insights from the frontline were shared in multiple national outlets, including The Guardian, The Wall Street Journal, and the New Yorker.Dr. Bankhead is passionate about ensuring healthcare workers feel an open door to discussing hardships \& trials concomitantly with their pursuit of excellent patient care. She served as a panelist at the inaugural ""Surgeons as Second Victims"" lecture at the American College of Surgeons annual meeting and helped create the roundtable ""Finding Comfort in Discomfort... Reflecting on Stories Told"" at the 2022 American Association for Academic Surgery presidential session. She is equally passionate about ensuring females feel an open door to starting and maintaining a productive career in surgery.Dr. Bankhead's leadership extends beyond her clinical practice. She currently is currently the vice chair of the Associate Membership Committee of the American Association for the Surgery of Trauma; she assumes the role of chair in September. She also serves on the Editorial Board for Trauma and Acute Care Surgery Open and Impact Surgery.". Dr. Bankhead is rated as an Experienced provider by MediFind in the treatment of Necrosis. Her top areas of expertise are Ogilvie Syndrome, Peptic Ulcer, Subarachnoid Hemorrhage, Splenectomy, and Gallbladder Removal.

Blase Carabello is a Cardiologist in Charleston,, South Carolina. Dr. Carabello is rated as an Advanced provider by MediFind in the treatment of Necrosis. His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Cardiac Ablation, and Angioplasty.

Dr. Thomas DiSalvo attended Harvard College and graduated with honors from the University of Cincinnati College of Medicine. Following medical residency and chief residency at Johns Hopkins Hospital in Baltimore and serving on faculty at Johns Hopkins School of Medicine, he completed fellowship training in cardiology at the Massachusetts General Hospital and Harvard Medical School. After ten years of clinical practice as an assistant professor of medicine at Harvard, he was recruited as medical director of the Vanderbilt Heart and Vascular Institute and as associate professor of medicine at Vanderbilt. In 2015, Dr. DiSalvo was recruited as professor of medicine and chief of the division of cardiology at MUSC. Throughout his career, he has been an active and busy clinical cardiologist committed to the highest standards of excellence. As an educator, although he has had the privilege of educating students and physicians in training and lecturing at many national and international cardiology meetings, Dr. DiSalvo enjoys educating patients and their families even more, both in the clinic and at the bedside. Dr. Di Salvo is rated as an Experienced provider by MediFind in the treatment of Necrosis. His top areas of expertise are Apoplexy, Atrial Fibrillation, Pulmonary Edema, Cardiac Ablation, and Pacemaker Implantation.

Dr. Adrian Van Bakel graduated from the University of Louisville School of Medicine in 1981, completing a Ph.D. in pharmacology from that institution in 1983. He completed internal medicine residency and cardiology fellowship training at the Medical University of South Carolina and has been on the faculty at MUSC since 1991. Dr. Van Bakel served as the Medical Director of the Heart Failure and Cardiac Transplant Program from 1991-2017. He has been an integral part of a multi-disciplinary clinical team that has achieved excellent results in the areas of clinical heart failure management and cardiac transplantation. He is a member of a number of professional societies including: The American College of Physicians; the American Heart Association; the American College of Cardiology; the Heart Failure Society of America; and, the International Society of Heart and Lung Transplantation. He has served as a manuscript reviewer for several journals, such as: The Journal of Cardiac Failure; The Journal of Heart and Lung Transplantation; and, The American Journal of Transplantation. Dr. Van Bakel has been the principal investigator of many multi-center clinical trials in congestive heart failure and cardiac transplantation. His research interests include congestive heart failure management, novel immunosuppression strategies and the pharmacogenomics of drug absorption and metabolism. Dr. Van Bakel is rated as an Experienced provider by MediFind in the treatment of Necrosis. His top areas of expertise are Pulmonary Edema, Heart Failure, Arrhythmogenic Right Ventricular Cardiomyopathy, Cardiac Ablation, and Endoscopy.

Dr. Sheldon E. Litwin is a cardiologist with nationally recognized expertise in advanced cardiac imaging and its use in the diagnosis of heart disease and treatment of patients with heart disease. Dr. Litwin is board-certified in general cardiology, nuclear cardiology, echocardiography, and cardiovascular computed tomography (CT). He was recognized in 2014 in America's Top Doctors (Castle Connolly Medical Ltd.). He is a strong proponent of preventive cardiology and has a longstanding interest in weight loss as prevention and treatment for cardiovascular disease. He is an avid outdoorsman and exercise advocate who is passionate about caring for active adults who participate in sports or recreational exercise. Prior to coming to MUSC Health, Dr. Litwin was chief of the division of cardiology at Georgia Regents University from 2011 to 2014 and director of cardiac imaging at the University of Utah from 1993 to 2011. Dr. Litwin is involved in clinical trials using new therapies for heart failure with preserved ejection fraction (HFpEF). He has published more than 100 scientific papers and serves on several editorial boards and national committees.Dr. Litwin's medical degree was awarded by Washington University School of Medicine. He completed a residency at the University of Arizona and completed a cardiology fellowship at Beth Israel Hospital, Harvard Medical School. Dr. Litwin is rated as an Experienced provider by MediFind in the treatment of Necrosis. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Cardiomyopathy, Gastric Bypass, and Cardiac Ablation.

Dr. Tedford is a Professor of Medicine/Cardiology and holds the Dr. Peter C. Gazes Endowed Chair in Heart Failure at the Medical University of South Carolina (MUSC) in Charleston, SC. He currently serves as the section head of heart failure and medical director of cardiac transplantation. He also established and directs the Advanced Heart Failure and Transplant Fellowship Program at MUSC. Dr. Tedford is an internationally recognized clinical researcher and has published over 200 peer-reviewed original research manuscripts, invited expert reviews, editorials and book chapters. His research efforts are focused on hemodynamic assessment of right ventricle function and its interaction with the pulmonary circulation and left heart. This research spans the fields of pulmonary hypertension, left heart disease, exercise physiology, hemodynamics, systemic sclerosis and mechanical circulatory support. He participates on several scientific advisory boards, clinical trial steering committees, and serves as a hemodynamic core laboratory for clinical pharmaceutical trials. He is co-chair of the PH due to left heart disease task force for 7^th^ World Symposium on Pulmonary Hypertension. He is a deputy editor for the *Journal of Heart and Lung Transplantation* and serves on the editorial board for *Circulation: Heart Failure CHEST*and *JACC: Heart* *Failure.*. Dr. Tedford is rated as an Experienced provider by MediFind in the treatment of Necrosis. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Pulmonary Hypertension, Heart Failure, Heart Transplant, and Cardiac Ablation.

Dr. Zile is a graduate of Rush University School of Medicine. He did his internal medicine residency at Rush Presbyterian St. Lukes Medical Center in Chicago, a clinical cardiology fellowship at Tufts-New England Medical Center in Boston and a research cardiology fellowship at the Department of Veterans Affairs Medical Center, Boston. Dr. Zile is currently the Charles Ezra Daniel professor of medicine at the Medical University of South Carolina.He also serves as the director of cardiology at the Ralph H. Johnson Department of Veteran's Affairs Medical Center in Charleston. He is an adjunct professor of bioengineering at Clemson University.Dr. Zile's research career has involved both basic laboratory research examining the mechanisms of disease development and progression and translational clinical research examining the application of these basic mechanisms to development of effective treatment methods.Dr. Zile is a recognized leader in the areas of cardiac function, congestive heart failure, diastolic heart failure and valvular heart disease. His research is supported by grants from the National Heart, Lung and Blood Institute, the American Heart Association, the Department of Veterans Affairs and the Medical University of South Carolina.Dr. Zile is the author of over 100 peer-reviewed publications. He is a member of a number of professional societies including the American College of Physicians, American Federation of Clinical Research, American Heart Association, American College of Cardiology, the Heart Failure Society of America, International Society of Heart Failure, and the American Physiology Society. Dr. Zile has served on the research, educational and program committees of these organizations. He serves on the editorial boards of the Journal of the American College of Cardiology and Circulation and is an editorial consultant to a number of others including Circulation Research, Journal of Clinical Investigation and the American Journal of Physiology. Dr. Zile is a member of the Association of University Cardiologists and a member of the ABIM Subspecialty Board on Cardiovascular Disease. Dr. Zile is rated as an Experienced provider by MediFind in the treatment of Necrosis. His top areas of expertise are Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Hypertensive Heart Disease, Pacemaker Implantation, and Cardiac Ablation.

A native of New York, Dr. Michael R. Gold graduated from SUNY at Stony Brook in 1975. He received his medical degree from the University of Colorado in 1985 and his Ph.D. degree from the University of Virginia in 1979. He completed his residency and cardiology fellowship at Massachusetts General Hospital in 1991. Immediately thereafter, Dr. Gold joined the faculty of University of Maryland where he was the director of the cardiac electrophysiology service and assistant professor of medicine and physiology. In 2001, he became professor of medicine in the Department of Medicine. From 2002 to 2015, Dr. Michael R. Gold was the chief of cardiology, Michael E. Assey professor of medicine and medical director of the Heart and Vascular Center at the Medical University of South Carolina in Charleston, South Carolina. Dr. Gold is the author of over 250 publications. He is board certified by the American Board of Internal Medicine, in cardiovascular disease and clinical cardiac electrophysiology. His special interests include electrophysiology, adult cardiology and arrhythmias and he is a pioneer in the development of new defibrillation techniques and pacing for congestive heart failure. Dr. Gold is rated as an Experienced provider by MediFind in the treatment of Necrosis. His top areas of expertise are Arrhythmias, Heart Failure, Atrial Fibrillation, Cardiac Ablation, and Pacemaker Implantation.

Dr. Jan Griffin completed her residency in internal medicine at the University of North Carolina in Chapel Hill and cardiology fellowship at Johns Hopkins Hospital. She then did a fellowship in advanced heart failure and transplant cardiology at Columbia University Irving Medical Center, where she continued as an assistant professor of medicine.Her research focuses on infiltrative cardiomyopathies, particularly cardiac amyloidosis and cardiac sarcoidosis. She is ABIM board certified in internal medicine, cardiology and advanced heart failure and transplant cardiology. Dr. Griffin is rated as an Experienced provider by MediFind in the treatment of Necrosis. Her top areas of expertise are Cardiac Amyloidosis, Primary Amyloidosis, Sarcoidosis, Cardiomyopathy, and Heart Transplant.

Dr. Brian Houston is a cardiologist specializing in the management of advanced heart failure, including the care of patients before and after heart transplantation or left ventricular assist device (LVAD). After graduating from Emory University School of Medicine, Dr. Houston completed residency at Johns Hopkins Hospital in Baltimore, Maryland. He was invited to serve as an assistant chief of service of the Thayer Firm at Johns Hopkins Hospital, and he spent that year caring for patients and instructing residents and medical students. He remained at Johns Hopkins for his general cardiology fellowship and spent an additional year of fellowship there training in the care of advanced heart failure, LVADs, and transplantation. Dr. Houston has been invited to present his research work at international scientific meetings. He has a particular interest in cardiac sarcoidosis and in the effects of LVAD support on the gastrointestinal tract, blood, and the right side of the heart. He was honored to be named a finalist for the American Heart Association's Young Clinician Award in 2015. Dr. Houston believes that each patient with heart failure is unique and that, to live their best life, they require a caring and comprehensive approach from a dedicated medical team. Dr. Houston is rated as an Experienced provider by MediFind in the treatment of Necrosis. His top areas of expertise are Sarcoidosis, Heart Failure, Pulmonary Hypertension, Heart Transplant, and Cardiac Ablation.

Thomas Appleby is a Vascular Surgeon and a General Surgeon in Charleston, South Carolina. Dr. Appleby is rated as a Distinguished provider by MediFind in the treatment of Necrosis. His top areas of expertise are Carotid Artery Disease, Arterial Insufficiency, Peripheral Artery Disease, Carotid Artery Surgery, and Myringotomy. Dr. Appleby is currently accepting new patients.

Minh Tran is an Internal Medicine provider in Charleston, South Carolina. Dr. Tran has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Necrosis. His top areas of expertise are Hypertensive Heart Disease, Heart Failure with Preserved Ejection Fraction (HFpEF), Pediatric Myocarditis, Pacemaker Implantation, and Heart Bypass Surgery.

James Smith is a Cardiologist in Charleston,, South Carolina. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Necrosis. His top areas of expertise are Pediatric Myocarditis, Atherosclerosis, Angina, Coronary Heart Disease, and Pacemaker Implantation.